Companies Related to "Indices of Severity and Prognosis for Sickle Cell Disease" [Most Relevant Company Matches] RSS

09:58 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Indices of Severity and Prognosis for Sickle Cell Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Indices Severity Prognosis Sickle Cell Disease" Companies 1–25 of 3,800+


Imara Inc.

Imara Inc., a Cydan Development company, is dedicated to developing novel therapeutics for patients with sickle cell disease. Imara is developing IMR-687, a highly selective, potent small molecule inhibitor of PDE9, to treat patients with sickle cell disease. The company was launched following an 18-month diligence and de-risking scientific collabor...

Sickle Cell Foundation of Tennessee

“Our mission is to provide social services, including health, education and life skills, to enhance the quality of life and self-sufficiency of individuals living with Sickle Cell,” said Thompson. “Everything we plan builds our capacity and extends our reach to serve more people. We must grow because there are people in pain who need our help.â€...

Emmaus Life Sciences, Inc.

Emmaus Life Sciences is dedicated to the discovery, development and commercialization of innovative treatments and therapies for rare diseases. The Company’s research on sickle cell disease and sickle beta-0 thalassemia was initiated by Dr. Niihara at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. The therapy has Orphan D...

National Stomp Out Sickle Cell Walk

The William E. Proudford Sickle Cell Fund

Angiogenix, Inc.

Angiogenix is a biopharmaceutical company developing therapeutic solutions for chronic vascular disease. We are a product-oriented company. Our products generally address the improvement of blood flow by improving vascular function. Within this framework, our products cover a broad range of types and indications, from novel combination drugs to a new proprietary drug for sickle cell disease. We al...

Multiple Myeloma Research Foundation and Adaptive Biotechnologies

Adaptive Biotechnologies Corporation is a platform-based, diagnostic-driven company that leverages NGS to profile T-Cell and B-Cell Receptors. This breakthrough enables in-depth characterization of the adaptive immune system, which is the primary defense against cancer. By incorporating immunosequencing into clinical care, Adaptive can enhance the diagnosi...


HopeLab is a non-profit organization founded in 2001 by Board Chair Pam Omidyar. HopeLab combines rigorous research with innovative solutions to improve the health and quality of life of young people living with chronic illness. HopeLab applies a research-based, customer-focused development model to create products that address chronic illnesses in young people, including cancer, obesity, sic...

Celtor Biosystems A/S

CelTor is a product-based biotechnology company engaged in the discovery and development of novel drug compounds for the treatment of inflammatory disease using its proprietary CelBase™ Disease Models. These disease models replicate cell-to-cell interactions that are critical in the inflammation cascade.

Selexys Pharmaceuticals Corporation

Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that develops and commercializes therapeutics to treat inflammatory and thrombotic diseases. The company has completed research and is in preclinical development of two drug candidates, a monoclonal antibody and a glycosulfopeptide, that have broad application for the treatment of acute and chronic inflammatory disorders. Th...

Medinox, Inc

Medinox, Inc. is a San Diego-based pharmaceutical company that is developing new small molecule drugs to treat a wide variety of unmet medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The Company's research and clinical development programs fall into two broad categories: 1) nitric oxide neutralizers, and 2) novel prodrugs.

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that: * Address currently unmet medical needs * Suggest a clear-cut development profile * Provide an opportunity to be first-to-market The company's product portfolio is comprised of three approved products and multiple investigational product...

Personalized Pharmaceutical Systems

Personalized Pharmaceutical Systems (PPS) is a cutting edge clinical trial enhancement and market differentiation company designed to dramatically reduce risk for pharmaceutical companies in both drug development and post-market entry phases. PPS novel enrichment technology utilizes inter-individual variability, that currently confounds drug trials, to enhance efficacy outcomes and/or significantl...

National MS Society

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to loss of vision and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us ...

DeuteRx LLC

DeuteRx is pioneering ‘deuterium-enabled chiral switching’ (DECS), a revolutionary approach to improve racemic (a mixture of two mirror-image compounds or enantiomers) small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. Numerous drugs are still developed and marketed as racemic mixtures...

U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell-based therapies that prevent or treat disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances ...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics ( develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs. The Presage ST2 Assay has been CE Marked and cleared by the US FDA. Critical Diagnostics has exclusive worldwide rights to ST2 for the diagnosis and prognosis of cardiovascular ...

Opsis Therapeutics

Opsis Therapeutics is a company focused on discovering and developing new medicines to restore vision to patients suffering from retinal diseases. By combining recent innovations in induced pluripotent cell (iPSC) manufacturing, retinal cell differentiation, functional biomaterials, pre-clinical models of retinal disease, and cell therapeutic delivery tech...

bluebird bio, Inc.

bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options. The company’s novel approach uses stem cells harvested from the patientâ...


VasSol, is founded on 12 years of multidisciplinary research and clinical work conducted at the University of Illinois at Chicago. Bringing together experts in the fields of circulatory fluid dynamics and computer modeling, VasSol developed NOVA(R), a vascular analysis technology, which helps answer the fundamental questions healthcare professionals confront when treating vascular disease: wha...

International Severity Information Systems, Inc


National Stem Cell Holding, Inc.

National Stem Cell Holding, Inc. is a biotechnology company focused on the development and commercialization of cell therapeutics primarily for diabetes and cardiac disease, and cosmetics derived from stem cells. For more information, visit, and

Cell Therapy Foundation

The Cell Therapy Foundation is a not-for-profit organization committed to advancing the treatment of disease using adult stem cells. Emerging as a leader in raising funds for adult stem cell research, Cell Therapy Foundation strives to increase awareness about adult stem cells, to fund adult stem cell research addressing several specific diseases, and to accelerate the rate of research and clini...

Univec, Inc.

Univec, Inc., a minority business enterprise (MBE), is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on dise...

More From BioPortfolio on "Indices of Severity and Prognosis for Sickle Cell Disease"

Quick Search


Corporate Database Quicklinks